• Yanchao Dong and Jianli An.
• From the Department of Interventional Treatment, First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China.
• Ann Saudi Med. 2024 Nov 1; 44 (6): 414421414-421.

BackgroundAs a proven and preferred technique for hemoptysis, bronchial artery embolization (BAE) cannot avoid the possibility of postoperative recurrence; however, few studies have examined the causes of hemoptysis recurrence after BAE.ObjectivesIdentify the risk factors for hemoptysis recurrence after BAE treatment.DesignRetrospective.SettingTertiary training and research hospital.Patients And MethodsA retrospective analysis was conducted on 406 patients with hemoptysis, 55 patients who developed with recurrent postembolization hemoptysis, covering the period from January 2011 to January 2021. Single factor analysis and multiple factor logistic regression were used to analyze high-risk factors for hemoptysis recurrence.Main Outcome MeasuresThe incidence and risk factors for recurrence hemoptysis associated with transcatheter BAE.Sample Size406 patients.ResultsMultivariate logistic regression analysis showed that preoperative computed tomography angiography (CTA) (odds ratio [OR]: 0.052, 95% CI: 0.012-0.225), tumor-related hemoptysis (OR: 20.753, 95% CI: 6.778-63.545), pleural thickening (OR: 3.168, 95% CI: 1.081-9.286), and bilateral lung lesions (OR: 8.442, 95% CI: 2.449-29.101) had a statistically significant impact on the recurrence of hemoptysis after BAE.ConclusionsPreoperative CTA serves as a protective factor against hemoptysis recurrence, whereas tumor-related hemoptysis, pleural thickening, and bilateral lung diseases are significant risk factors for hemoptysis recurrence following interventional therapy.LimitationsThis was a retrospective analysis of a single center with a small sample, which may have a certain degree of recall bias when collecting data, thus, reducing the reliability of the results.

21 keywords...

hide…